Pharmaledger: bridging the gap between healthcare and technology
In the heart of Switzerland, the PharmaLedger Association, established in March 2022, is a testament to the power of collaboration. Born from the PharmaLedger project, which spanned from 2020 to 2022, this not-for-profit Association is the fruit of a remarkable public-private partnership. It brought together pharmaceutical giants and EU public partners, a diverse coalition comprising hospitals, universities, patient organizations, and technology firms. Their shared vision: to revolutionize healthcare through cutting-edge blockchain technology, laying the groundwork for a Digital Trust Ecosystem in Healthcare (DTE-H).
At its inception, the association’s focus was centered on leveraging blockchain technology to create this Digital Trust Ecosystem in healthcare. However, as the project unfolded, it became evident that it was less about the technology itself and more about the vital elements of collaboration and trust. The foundation of this ecosystem is rooted in the digital, grounded in trust, and fundamentally bolstered by blockchain technology, though the focus has since pivoted primarily to these core values.
The journey hasn’t been without its challenges. Bridging diverse stakeholders, from pharmaceutical industry experts to academia and healthcare providers, was certainly an early hurdle. Yet, by fostering a culture of collaboration and mutual respect during the project’s planning phase, these seemingly distinct entities found common ground. Each voice, regardless of the organization’s size, was heard, respected and valued resulting in remarkable outcomes and meaningful progress.
ePI: A Healthcare Information Revolution
Notably, this year, the association celebrated the release of its inaugural product, electronic product information (ePI), commonly referred to as the e-leaflet, an integral part of the project. This first product of PLA’s Product Trust Platform™ marks the initial stride toward our vision for a global digital healthcare.
Unlike static PDFs, ePI utilizes dynamic updates via a secure network, ensuring the most current information is readily available to patients, healthcare providers, and caregivers, fostering an environment of trust and accessibility. ePI also champions shared infrastructure, eliminating third-party proprietary technology, which reduces enhancement and maintenance costs while embracing patient organizations’ input.
The launch of this revolutionary product in a ‘qualified state’ signifies that the product has been rigorously tested and documented. This achievement marked a strategic milestone for the association, signifying not just a sustainable, paperless solution but a patient-centric shift in healthcare information access, with profound implications for the industry’s future.
The Vision: From ePI to Expansive Ecosystem
So, what’s on the horizon for PharmaLedger? A pivotal goal is the successful adoption of ePI, backed by a mass of association members, including early adopters from the pharmaceutical industry.
The aim is to pilot the product and gather feedback from patient organizations, healthcare professionals and patients, whose experience is fundamental and guides us on what and how to explore potential applications. Success in this endeavor is anticipated to attract more members, expanding the ecosystem’s reach. With greater resources, the association plans to invest in other use cases, particularly in clinical trials, health data, and supply chain domains.
The ultimate objective is to grow to 200+ members and introduce additional products. Within the PharmaLedger Network’s pipeline are potential features like counterfeit medicine detection, medication adherence prompts, adverse health event reporting, integrations with other health applications, and a host of other innovative functionalities. Ultimately, PharmaLedger Association’s unique ethos is clear: it seeks to facilitate a decentralized network and empower its members and users, without becoming an overarching controlling entity.
Trust in Healthcare Technology: The Enduring Role
As for commonly held industry beliefs, there’s a notion that emerging technologies bring entirely new paradigms. However, reflecting on past experiences, such as using RFID tags for tracking shipments in the ’90s or employing advanced analytics for fleet maintenance, it’s apparent that trust ecosystems have been the driving force behind successful endeavors.
The model underpinning blockchain’s trust ecosystem has historical parallels, where partnerships compelled organizations to collaborate closely for mutual benefit and customer value, irrespective of the underlying technology. What remains constant is the importance of hard work and perseverance in implementing any system, no matter the cutting-edge technologies it may involve.
In an era of digital transformation, trust continues to be the compass guiding Pharmaledger towards a future where healthcare technology empowers, includes, and innovates for the betterment of all.
This article is based on an interview conducted by LogiPharma with Daniel Fritz, PharmaLedger Association’s Executive Director. The full interview can be heard here: https://lnkd.in/efdNkrn7